Safety of early antiplatelet administration in patients with acute ischemic stroke treated with alteplase (SEAPT-24)
Alteplase, a tissue-type plasminogen activator, is recommended for ischemic stroke patients presenting within 4.5 h. Due to bleeding risks, current guidelines advise delaying antiplatelet therapy for 24 h after alteplase. However, specific scenarios may require antiplatelet therapy to be given withi...
Gespeichert in:
Veröffentlicht in: | Journal of stroke and cerebrovascular diseases 2022-12, Vol.31 (12), p.106868-106868, Article 106868 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!